Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment

References

• George J K, Raskob G E. Clinica) decisions in idiopathic thrombocytopenic purpura. Hasp Practice 1997: 32: 159 70.
   Google Scholar
• American Society of Hematology FTP Practice Guideline Panel Diagnosis and treatment of idiopathic thrombocytopenic purpura. Am Family Physician 1996; 54: 2437–52.
   PubMedGoogle Scholar
• McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Internal Med 1997; 126: 307–14.
   PubMed Web of Science ®Google Scholar
• Blanchette V. Freedmnn J. Garvcy B. Management of chronic immune thrombocytopenic purpura in children and adults. Sem Hematol 1998: 35. 36–51.
   PubMed Web of Science ®Google Scholar
• George J N, Raskob G Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults. 5>w Hematol 1998; 35: S 8.
   Web of Science ®Google Scholar
• George J N, Raskob G H. Idiopathic thrombocytopenic purpura: diagnosis and management. Am J Med Sc 1998; 316: 87–93.
   PubMed Web of Science ®Google Scholar
• Tarantino M D. Goldsmith G. Treatment of acute immune thrombocytopenic purpura Sent Hematol 1998: 35: 28–35.
   Google Scholar
• Kclton J G. Murphy WG. Lucarelli A. et al. A prospective comparison of four techniques for measuring platelet-associated IgG. Br J Haematol 1989; 71: 97–105.
   PubMed Web of Science ®Google Scholar
• Mullcr-Eckhardt C. Kayser W. Mersch-Baumen K. et al. The clinical significance of plalelel-associaicd IgG: A study on 298 patients with various disorders. Br J Haematol 19S0; 46: 123–31.
   Google Scholar
• Terstappcn L W M M. Lokcn M R. Fivc-dimensionfll flow cytometry as a new approach for blood and bone marrow differentials. Cytometry 1988; 9: 548–56.
   PubMedGoogle Scholar
• van Move L, Goosserts W. van Duppcn V, Verwilghcn R L. Reticulocyte conni using thiazole orange. A flow cyromeiry method. Clin Lab Haeinat 1990; 12: 287–99.
   PubMedGoogle Scholar
• Pappas A A, Owens R B. Flick J T. Reticulocyte counting by How cytometry. A comparison with manual methods. Ann Clin Lab 5c/1M2: 22: 125–32.
   Google Scholar
• Tcrstappen L W M M. Levin J. Bone marrow cell differential counts obtained bv multidimensional flow Cytometry. Blood CeOs 1992: 18:311-30-
   Google Scholar
• Ault K A. Knovvlcs C In vivo biotinylation demonstrates lhai reticulated platelets are the youngest in the circulation. Exp Hematol 1995; 23: 996–1001.
   PubMed Web of Science ®Google Scholar
• Lee L G. Chen C-H. Chiù L A. Thiazole orange: a new dye for reticulocyte analysis. Cytometry 1986; 7: 508 17.
   Google Scholar
• Kicnast K, Schmetz G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990; 75: 116–21.
   PubMed Web of Science ®Google Scholar
• Ault K A. Rinder II M, Mitchell J. Ciimody M B, Vary G P H. Hillman R S. The significance of platelets with increased RNA content (reticulated platelets). Am J Clin Pallini 1992; 98: 637–46.
   PubMed Web of Science ®Google Scholar
• Gyongyossy-Issa M 1 C. Miranda J. Devine D V. Generation of reticulated platelets in response to whole blood donation or plateletphcresis. Transfusion 2001; 41: 1234.
   Google Scholar
• Rinder H M, Munz U J. Ault K A. Bonau J L, Smith B R. Reticulated platelets in the evaluation of ihrombopoictic disorders. Arch Pathol Lab Med 1993; 117; 606–10.
   PubMed Web of Science ®Google Scholar
• Bona» J L. Rinder H M, Smith B R. Detenni nation of the percentage of TO-positive, “reticulated” platelets using autologous erythrocyte TO fluorescence as an internal standard. Cytometry 1993: 14: 690 4.
   Google Scholar
• Watanabe K, Takeuchi K. Kawai Y. Ikeda Y. Kubota F. Nakamoto H. Automated measurement of reticulated platelets in estimating ilirombopoiesis. Eur J Haematol 1995; 54: 163–71.
   PubMed Web of Science ®Google Scholar
• Saxon B R. Mody M. Blanchette V S. Frccdman J. Reticulated platelet counts in the assessment of thrombocytopenic disorders. Acta Paediat 1998; 424: 65 70.
   Google Scholar
• Warner M N. Moore J C, Warkemin T E. Santos A V. Kcllon J Ci. A prospective study of protein-specific assays used to investigale idiopathic thrombocytopenia. Brit J Haematol 1999; 104: 442–7.
   PubMed Web of Science ®Google Scholar
• Winiarski J. Measurement of platelet antibodies; where do we stand? Acta Paedtat 1998; 424: 51–3.
   Google Scholar
• George J N, Raskob G E. Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults. Sem Haematol 199S: 35: 5–8.
   Google Scholar
• Imbach P. Immune thrombocytopenia in children: the immune character of destructive thrombocytopenia and the treatment ofbleeding. Sem Thromb Hemosias 1995; 21; 305–12.
   PubMed Web of Science ®Google Scholar
• Tassies D. Reverter J-C, Cases A. Escolar G. Víllamor N. Lopez-Pedrcl J. ri al. Reticulated platelets in uremie patients: effect of hemodialysis and continuous ambulatory peritoneal dialysis Am J Heamtol 1995; 50: 161–6.
   Google Scholar
• Himmelfarb J. Holbrook D. McMonagle E. Ault K. Increased reticulated platelets in dialysis patients. Kidney International 1997;51:834–9.
   PubMed Web of Science ®Google Scholar
• Belluci S. Dysmegakaryocytopoicsis and thromhopoiesis in autoimmune thrombocytopenias, Cnm/ues rendus des Seances de la Société de Biologie et ses Filiales 1996; 190: 541–8.
   Google Scholar
• Parker R I. Sicgel R S. Ralaje/ak M Z. Gewirlz A M. Delicien! in vitro magakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia. J Paed Haem One 1998; 20: 196–201.
   PubMed Web of Science ®Google Scholar
• Bailem P J. Segal Ci M. Stralton J R. Gernscheimer T, Adamson J W. Slichler S J. Mechanism of thrombocytopenia in chrome autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. J Clin Invest 1987; 80; 33–40.
   PubMed Web of Science ®Google Scholar
• Tomer A. Hanson S R. Harker L A. Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. J Lab & Clin Med 1991; 118: 546–54.
   PubMed Web of Science ®Google Scholar
• Stohlwciz P. Sticglcr G. Jilma B. Dettkc M. Hocker P. Panzer S. Measurement of the levels of reticulated platelets after plateletphcrcsis to monitor activity of thrombopoicsis. Transfusion 1998; 38: 454–8.
   PubMed Web of Science ®Google Scholar
• Samuclsson A. Towers T L, Ravctch J V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001:291:484-6.
   Web of Science ®Google Scholar
• Koike Y. Yoncyama A. Shirai J. Ishida T. Snoda H. Miya7aki K, et al. Evaluation of thrombopoicsis in thrombocytopenic disorders by simultaneous measurement oí reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Hemostas 1998; 79: 1106–10.
   PubMed Web of Science ®Google Scholar
• Hou M. Andcrsson P O, Stockclberg D. Mellqvist U H. Ridell B. Wadenvik H. Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakrvocytcs. Brit J Haematol 1998; 101: 420 4.
   Google Scholar
• Nagata Y. Shozaki Y. Nagahisa ÏI. Nagasawa T. Abe T. Todokoro K. Serum thrombopoietin level is not regulated by transcription but by lhe total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemostas 1997; 77: 808–14.
   PubMed Web of Science ®Google Scholar
• Nagasawa T. Hascgawa Y, Shimizu S. Kawashima Y. Nishimura S, Suzukawa K. et ut. Scrum thrombopoietin level is mainly regulated by megakaryocyte mass rather thau platelet mass in human subjects. Brit J Haematol 1998; 101: 242 4.
   Google Scholar
• Majluf-Cruz A, l.una-Castanos G. Huitron S. Nieto-Cisneros L. Usefulness of a low-dose intravenous immunoglobulin regimen for the treatment of thrombocytopenia associateti with AIDS. Am J Hematol 1998; 59: 127–32.
   PubMed Web of Science ®Google Scholar
• Chia W K, Blanchelte V. Mody M. Wright i F. Frcedman J. Characterization of IIIV-1 -specific antibodies and H1V-I-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Brit J Haematol 1998; 103: 1014–22.
   PubMed Web of Science ®Google Scholar
• Bailem P J. Bclzberg A. Devine DV, Lyster D. Spruslon B. Chambers H. et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. Ne» England J. Med. 1992; 327: 1779–84.
   PubMed Web of Science ®Google Scholar
• Williams S B, Sano M. Smith N. Home M. Yarchoan R. Wyvill K. et al. Glycocalicin levels in the plasma of H1V+ patients: an indicator o(platelet turnover. J Lab Clin Med 1998; 132: 303–7.
   PubMed Web of Science ®Google Scholar
• Toulon P. Hcmostasis and the human immunodeficiency virus (HIV) infection. Annales de Biologie Clinique 1998; 56: 153–00.
   PubMed Web of Science ®Google Scholar
• Cole J L. Morzec H M. Gunthcl C J. Karpatkin S. Worford L, Sundell I B. et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. WW 1998; 91: 3239–46.
   Google Scholar
• Young G, l.oechelt B J. Rakusan T A. Nichol J L, Luban N L C. Thrombopoietin levels in IITV-associated thrombocytopenia in children. J Paed 1998: 133: 765 9.
   Google Scholar